SURGICAL/CRITICAL CARE
The Tru-Ddevice, part of PDI’s market-leading environment of care solutions, is a portable UVC disinfection robot that delivers one automated, measured dose of UVC to consistently disinfect a room, resulting in the ability to document disinfec- tion results after each and every room treatment. he ru- device ensures signifi cant microorganism inactiva- tion in direct and shadowed areas, reducing human error in the disinfection process and documenting results for each cycle. Validated by more than 10 inde- pendent studies, the Tru-D device’s combined automated, measured dosing capabilities and real-time usage-tracking features make it one of the most advanced UVC disinfection sys- tems available, according to the company. “As the emphasis on providing the clean- est environment possible grows, hospi- tals will continue to seek out new ways to utilize technology in all areas of a facil- ity. Further, as prominent organizations such as the AHA, the CDC and ASHE begin to stress the use of enhanced terminal room disinfection technol- ogy, I believe UVC disinfection will become a standard of care for health care facilities.”
Tru-D SmartUVC The future of healthcare is autonomous
An Accenture survey found 71% of health executives believe robotics will enable the next generation of services in the physical
world.4
Aaron Chau, OhmniLabs Product Manager & Team Lead, comments on how its OhmniClean autonomous UV-C disinfec- tion robot improves room disinfection in the hospital environment.
“We developed OhmniClean to address a critical need in the healthcare market for fast, simple and effective disinfec- tion. The future is autonomous, which is why OhmniClean uses autonomous tech to deliver more consistent disinfec- tion without shadowing. The result is whole room coverage not a-chievable by manual units.”
Chau notes how OhmniClean’s autono-
mous operation improves staff effi ciency. Since the robot navigates on its own and does not require repositioning several times in one room, operators have more time for higher-level work. Its proprietary mapping technology, QuickMap, makes the robot easy to use; new operators can be trained in as little as fi ve minutes. Independent testing shows OhmniClean rapidly eliminates pathogens like MRSA, , and -o- with an effi cacy of 99.999%, improving environmental and infection prevention standards aimed to combat HAIs. Plus, auditable reports are available in real-time to dem- onstrate that proper disinfection has been completed. EVS
OhmniLabs OhmniClean autonomous UV-C disinfection robot
IN HEALTHCARE ENVIRONMENTS FOR OVER A DECADE The Halo Disinfection System®
ELIMINATING PATHOGENS While EVS focus has been on emerging infections like COVID-19 and now
Monkeypox, pathogens causing healthcare-associated infections (HAIs) like C. diff and C. auris are still difficult to eliminate inside facilities.
Hospitals and healthcare facilities require reliable disinfection and proper infection control, but many solutions can’t reach everywhere. Halosil has over a decade of successfully combating pathogens with the Halo Disinfection System, which pairs sporicidal HaloMistTM
(EPA Reg. No. 84526-6) with the HaloFogger®
with repeatable efficacy and reliable results. The Halo Disinfection System offers: Proven whole-room disinfection
Sporicidal efficacy; kills 99.9999% of C. diff spores
On EPA List K (C. diff), List N (COVID-19), and List Q (Monkeypox)
HALO SEALED ™
Meet us at Booth 208 to hear about our AHE Exchange 2022 Special Price Offer Learn more at
halosil.com/ahe-2022
to ensure whole-room coverage
Touchless, labor saving application; affordable cost
No wetting during application, no residue & safe for sensitive equipment
hpnonline.com • HEALTHCARE PURCHASING NEWS • September 2022 13
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
